ALNY vs HLX · P/E 76, rev $1.29B vs P/E 89, rev $570.7M
Alnylam Pharmaceuticals Inc (ALNY) versus Helix Energy Solutions Group Inc (HLX) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Helix Energy Solutions Group Inc (HLX) is a oil & gas equipment & services company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported HLX revenue for 2026-06-30 was $570.7M. Net income was $9.3M. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. HLX currently screens at market cap $1.31B and trailing P/E 88.7.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. HLX currently screens at market cap $1.31B and trailing P/E 88.7.
Not investment advice. Open the ALNY and HLX stock pages for the full models.
Not investment advice.